SAN DIEGO, Oct 19, 2004 /PRNewswire-FirstCall via COMTEX/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD) announced today that Uli Hacksell, Ph.D., Chief ExecutiveOfficer, will present at the Rodman & Renshaw Techvest 6th Annual HealthcareConference on October 26, 2004, at 3:50 pm Eastern Time at the Waldorf=AstoriaHotel in New York City.
A live webcast of ACADIA's presentation will be accessible on thecompany's website, www.acadia-pharm.com, under the investor relations sectionand an archived recording will be available on the website through November 9,2004.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of novel treatmentsfor central nervous system disorders. ACADIA currently has five drug programsin clinical and preclinical development directed at large unmet medical needsand major commercial markets, including Parkinson's disease, schizophrenia,chronic pain, and glaucoma. Using its proprietary drug discovery platform,ACADIA has discovered all of the drug candidates in its product pipeline.ACADIA's headquarters and biology research facilities are located in SanDiego, California and its chemistry research facilities are located inCopenhagen, Denmark.
Contact:
ACADIA Pharmaceuticals Inc.
Thomas H. Aasen, Vice President and Chief Financial Officer
+1 858-558-2871
ir@acadia-pharm.com